DMT310-001 Topical in the Treatment of Acne Vulgaris
Status: | Recruiting |
---|---|
Conditions: | Acne, Acne, Dermatology |
Therapuetic Areas: | Dermatology / Plastic Surgery |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/14/2018 |
Start Date: | May 22, 2018 |
End Date: | February 13, 2019 |
Contact: | Dermata Study Director |
Email: | clinicaltrial@dermatarx.com |
Phone: | 858 228-0880 |
A Study of Tolerability, Safety, And Efficacy, of DMT310 In Patients With Acne Vulgaris
The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder
mixed with diluent in male and female patients with moderate to severe facial acne vulgaris.
mixed with diluent in male and female patients with moderate to severe facial acne vulgaris.
Inclusion Criteria:
- Patient is male or non-pregnant female at least 18 years of age.
- Clinical diagnosis of moderate to severe acne vulgaris as determined by:
Investigator's Global Assessment (IGA) at Randomization Patient has at least 20 but not
more than 50 inflammatory lesions on the face Patient has at least 20 but not more than 100
noninflammatory lesions on the face
- Patient is willing to apply the Investigational Product as directed
- Patient is willing and able to comply with the protocol
Exclusion Criteria:
- Patient is pregnant or planning to become pregnant
- Patient is taking a topical therapy on the face which may affect the patient's acne
We found this trial at
9
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials